Methods for the selective modification of viral nucleic acids

Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or... – Inactivation or attenuation; producing viral subunits

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 2, C12N 706, A01N 102

Patent

active

061365866

ABSTRACT:
This invention provides means and methods of inactivating viruses and other organisms in cell-containing or biopolymer-containing compositions without significant alteration of proteins or other biopolymers by contacting such compositions with selective ethyleneimine oligomer inactivating agents, such as the trimer or tetramer.

REFERENCES:
patent: 3492289 (1970-01-01), Symm et al.
patent: 4036952 (1977-07-01), Bauer et al.
patent: 4058599 (1977-11-01), Bauer et al.
patent: 4841023 (1989-06-01), Horowitz
patent: 5000951 (1991-03-01), Bass et al.
patent: 5055485 (1991-10-01), Geacintov et al.
patent: 5120649 (1992-06-01), Horowitz et al.
patent: 5232844 (1993-08-01), Horowitz et al.
patent: 5374424 (1994-12-01), Kelsey et al.
patent: 5559250 (1996-09-01), Cook et al.
Murphy, "Virus Taxonomy", pp. 15-57 in Fields et al., Fields Virology, Lippincott-Raven, Philadelphia, 1996.
Creech et al., "Antitumor and Mutagenic Properties of a Variety of Heterocyclic Nitrogen and Sulfur Mustards," Medicinal Chemistry, 15: 739-746, 1972.
International search report for PCT/US96/14040 mailed Jan. 14, 1997.
International preliminary examination report for PCT/US96/14040 mailed Dec. 9, 1997, 6 pages.
Bahnemann, H.G., "Inactivation of Viruses in serum with Binary Ethyleneimine", Journal of Clinical Microbiology, vol. 3, No. 2, pp. 209-210 (1975).
Bahnemann, H.G., "Inactivation of Viral Antigens for Vaccine Preparation with Particular Reference to the Application of Binary Ethylenimine", Vaccine, 8:299-303 (1990).
Budowsky et al., "Inactivation of the phage MS2 infectivity by the action of ethyleneimines," Biorg. Khim. 11:989-991 (1985) (in Russian). English Abstract provided, 1 page.
Budowsky, E.I. and Zalesskaya, M.A., "Principles of selective inactivation of viral genome. v. Rational selection of conditions for inactivation of the viral suspension infectivity to a given extent by the action of B-propiolactone," Vaccine 9:319-325 (1991).
Budowsky, E.I. et al., "Principles of Selective Inactivation of the Viral Genome; Dependence of the Rate of Viral RNA Modification on the Number of Protonizable Groups in Ethyleneimine Oligomer", Vaccine Research, 5(1):29-39 (1996).
Dermer, O.C. and Ham, G.E. Ethyleneimine And Other Aziridines, Acad. Press, NY-London (1969), pp. 249-285.
Earley, J.E et al., "Reactions of Ethylenimines. IX. The Mechanisms of Ring Openings of Ethylenimines in Acidic Solutions," J. Am Chem. Soc. 80:3458-3462 (1958).
King, "Evaluation of Different Methods of Inactivation of Newcastle Disease Virus and Avian Influenza Virus in Egg Fluids and Serum," Avian Diseases 35:505-514 (1991).
Kochetkov, N.K. and Budowsky, E.I. eds., Organic Chemistry of Nucleic Acids, Part A, Plenum Press, London-New York, pp. 48-55, (1972).
Kostyanovskii et al., "Oligomers of azridines and N-beta-azridinoethylamides," Bulletin of Academy of Sciences of the USSR, Division of Chemical Science vol. 37(11):2315-2325, May 20, 1989. (Translated from IzvestiyaAkademi Nauk SSSR, Seriya Khimicheskaya 11:2566-2575).
Prodouz et al., "Inhibition of Merocyainine 540-mediated Photosensitization of Platelets and Viruses," Transfusion 31:415-422 (1991).
Race, E. et al., "An Experimental Chemically Inactivated HIV-1 Vaccine induces Antibodies that Neutralize Homologous and Heterologous Viruses", Vaccine, 13(1):.54-60 (1995).
Tanirbergenov, T.B. et al., "Regularities of mutagenic and toxic effects of ethyleneimine and its oligomers. A comparative study in the automated system SOS-chromotest and in standard bacterial test systems," Genetika 24:763 (1998) (in Russian). English translation provided, 5 pages.
Van Etten,, R.L. and Dolhum, J.J., "Effects of Hydrogen-Bond Formation by Phenols on the Conformational Equilibrium of trans-1,2-Dimethyl-3-isopropylaziridine," J. Org. Chem. 33:3904-3907 (1968).
Wagner et al., "Approaches to the Reduction of Viral Infectivity in Cellular Blood Components and Single Donor Plasma," Transfusion Med. Rev. V:18-32 (1991).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods for the selective modification of viral nucleic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for the selective modification of viral nucleic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the selective modification of viral nucleic acids will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1962417

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.